Michael Berry

Chief Tech/Sci/R&D Officer at EVEREST MEDICINES LIMITED

59 year

Health Technology

Consumer Services

Michael Berry active positions

Companies	Position	Start	End
EVEREST MEDICINES LIMITED	Chief Tech/Sci/R&D Officer	2023-06-14	-

Companies	Position	Start	End
DYNAVAX TECHNOLOGIES CORPORATION	Corporate Officer/Principal	2015-01-31	2017-07-31
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	2013-09-30	2015-01-31
Novartis Vaccines & Diagnostics SL	Corporate Officer/Principal	2010-03-31	2013-08-31
ARCA BIOPHARMA, INC.	Director/Board Member	2005-03-31	2009-04-30
CLOVER BIOPHARMACEUTICALS, LTD.	Chief Tech/Sci/R&D Officer	2021-03-14	-

De Montfort University	Undergraduate Degree
The University of Manchester	Graduate Degree
University of Manitoba	Doctorate Degree

International

Operational

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Director/Board Member	1

Sectoral

Health Technology	6
Consumer Services	4

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	4
CLOVER BIOPHARMACEUTICALS, LTD.	Health Technology
ARCA BIOPHARMA, INC.	Health Technology
DYNAVAX TECHNOLOGIES CORPORATION	Health Technology
EVEREST MEDICINES LIMITED	Health Technology

Private companies	2
Novartis Vaccines & Diagnostics SL
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology

Private companies

Novartis Vaccines & Diagnostics SL

Health Technology